The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Harmer, C. J.
* Articles by Goodwin, G. M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Harmer, C. J.
* Articles by Goodwin, G. M.
Related Collections
* Symptoms/Dimensions
* Antidepressants
Am J Psychiatry 161:1256-1263, July 2004
© 2004 American Psychiatric Association


Article

Increased Positive Versus Negative Affective Perception and Memory in Healthy Volunteers Following Selective Serotonin and Norepinephrine Reuptake Inhibition

Catherine J. Harmer, D.Phil., Nicholas C. Shelley, B.A., Philip J. Cowen, M.D., F.R.C.Psych., and Guy M. Goodwin, D.Phil., F.R.C.Psych.

OBJECTIVE: Antidepressants that inhibit the reuptake of serotonin (SSRIs) or norepinephrine (SNRIs) are effective in the treatment of disorders such as depression and anxiety. Cognitive psychological theories emphasize the importance of correcting negative biases of information processing in the nonpharmacological treatment of these disorders, but it is not known whether antidepressant drugs can directly modulate the neural processing of affective information. The present study therefore assessed the actions of repeated antidepressant administration on perception and memory for positive and negative emotional information in healthy volunteers. METHOD: Forty-two male and female volunteers were randomly assigned to 7 days of double-blind intervention with the SSRI citalopram (20 mg/day), the SNRI reboxetine (8 mg/day), or placebo. On the final day, facial expression recognition, emotion-potentiated startle response, and memory for affect-laden words were assessed. Questionnaires monitoring mood, hostility, and anxiety were given before and after treatment. RESULTS: In the facial expression recognition task, citalopram and reboxetine reduced the identification of the negative facial expressions of anger and fear. Citalopram also abolished the increased startle response found in the context of negative affective images. Both antidepressants increased the relative recall of positive (versus negative) emotional material. These changes in emotional processing occurred in the absence of significant differences in ratings of mood and anxiety. However, reboxetine decreased subjective ratings of hostility and elevated energy. CONCLUSIONS: Short-term administration of two different antidepressant types had similar effects on emotion-related tasks in healthy volunteers, reducing the processing of negative relative to positive emotional material. Such effects of antidepressants may ameliorate the negative biases in information processing that characterize mood and anxiety disorders. They also suggest a mechanism of action potentially compatible with cognitive theories of anxiety and depression.




This article has been cited by other articles:


Home page
Br. J. PsychiatryHome page
S. E. Murphy, R. Norbury, U. O'Sullivan, P. J. Cowen, and C. J. Harmer
Effect of a single dose of citalopram on amygdala response to emotional faces
The British Journal of Psychiatry, June 1, 2009; 194(6): 535 - 540.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
M Di Simplicio, R Massey-Chase, P. Cowen, and C. Harmer
Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers
J Psychopharmacol, May 1, 2009; 23(3): 241 - 248.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
W. Merens, L. Booij, P. J. Haffmans, and A. van der Does
The effects of experimentally lowered serotonin function on emotional information processing and memory in remitted depressed patients
J Psychopharmacol, August 1, 2008; 22(6): 653 - 662.
[Abstract] [PDF]


Home page
JNMHome page
R. Arakawa, M. Okumura, H. Ito, C. Seki, H. Takahashi, H. Takano, R. Nakao, K. Suzuki, Y. Okubo, C. Halldin, et al.
Quantitative Analysis of Norepinephrine Transporter in the Human Brain Using PET with (S,S)-18F-FMeNER-D2
J. Nucl. Med., August 1, 2008; 49(8): 1270 - 1276.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
M. Taylor, S. Murphy, S. Selvaraj, M. Wylezinkska, P. Jezzard, P. Cowen, and J. Evans
Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy
J Psychopharmacol, July 1, 2008; 22(5): 473 - 476.
[Abstract] [PDF]


Home page
BMJHome page
P. Biegler
Autonomy, stress, and treatment of depression
BMJ, May 10, 2008; 336(7652): 1046 - 1048.
[Full Text] [PDF]


Home page
J PsychopharmacolHome page
M. Browning, C. Reid, P.J. Cowen, G.M. Goodwin, and C.J. Harmer
A single dose of citalopram increases fear recognition in healthy subjects
J Psychopharmacol, September 1, 2007; 21(7): 684 - 690.
[Abstract] [PDF]


Home page
Br. J. PsychiatryHome page
B. BEDIOU, F. ASRI, J. BRUNELIN, P. KROLAK-SALMON, T. D'AMATO, M. SAOUD, and I. TAZI
Emotion recognition and genetic vulnerability to schizophrenia
The British Journal of Psychiatry, August 1, 2007; 191(2): 126 - 130.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
R. NORBURY, C. E. MACKAY, P. J. COWEN, G. M. GOODWIN, and C. J. HARMER
Short-term antidepressant treatment and facial processing: Functional magnetic resonance imaging study
The British Journal of Psychiatry, June 1, 2007; 190(6): 531 - 532.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
H. D. Critchley, P. A. Lewis, M. Orth, O. Josephs, R. Deichmann, M. R. Trimble, and R. J. Dolan
Vagus Nerve Stimulation for Treatment-Resistant Depression: Behavioral and Neural Effects on Encoding Negative Material
Psychosom Med, January 1, 2007; 69(1): 17 - 22.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. Bowers, K. Miller, A. Mikos, L. Kirsch-Darrow, U. Springer, H. Fernandez, K. Foote, and M. Okun
Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli
Brain, December 1, 2006; 129(12): 3356 - 3365.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
M. J. Taylor, N. Freemantle, J. R. Geddes, and Z. Bhagwagar
Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action: Systematic Review and Meta-analysis.
Arch Gen Psychiatry, November 1, 2006; 63(11): 1217 - 1223.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J. Olesen, M. G Baker, T. Freund, M. di Luca, J. Mendlewicz, I. Ragan, and M. Westphal
Consensus document on European brain research
J. Neurol. Neurosurg. Psychiatry, August 1, 2006; 77(suppl_1): i1 - i49.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
A. C. M. Vergouwen
Initial rate of improvement in major depression
The British Journal of Psychiatry, August 1, 2006; 189(2): 189 - 189.
[Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Hurlemann, B. Hawellek, A. Matusch, H. Kolsch, H. Wollersen, B. Madea, K. Vogeley, W. Maier, and R. J. Dolan
Noradrenergic Modulation of Emotion-Induced Forgetting and Remembering
J. Neurosci., July 6, 2005; 25(27): 6343 - 6349.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org